KSPHF (Kissei Pharmaceutical Co) E10: $1.20 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KSPHF Kissei Pharmaceutical Co Ltd KSPHF
79 GF Score
Price $25.77
GF Value $31.34
! 1 Warning Sign
View Full Analysis

What is Kissei Pharmaceutical Co E10?

Kissei Pharmaceutical Co KSPHF -4.45% 79 E10 is $1.20 as of Mar. 2026. GuruFocus rates KSPHF with a GF Score™ of 79/100 and a GF Value™ of $31.34. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Kissei Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.421. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $1.20 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Kissei Pharmaceutical Co's average E10 Growth Rate was 8.50% per year. During the past 3 years, the average E10 Growth Rate was 8.10% per year. During the past 5 years, the average E10 Growth Rate was 9.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Kissei Pharmaceutical Co was 10.50% per year. The lowest was 2.50% per year. And the median was 8.55% per year.

As of today (2026-08-05), Kissei Pharmaceutical Co's current stock price is $25.77. Kissei Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was $1.20. Kissei Pharmaceutical Co's Shiller PE Ratio of today is 21.48.

During the past 13 years, the highest Shiller PE Ratio of Kissei Pharmaceutical Co was 28.31. The lowest was 14.95. And the median was 19.24.


Kissei Pharmaceutical Co  (OTCPK:KSPHF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Kissei Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=25.77/1.20
=21.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Kissei Pharmaceutical Co was 28.31. The lowest was 14.95. And the median was 19.24.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Kissei Pharmaceutical Co E10 Related Terms


Kissei Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Kissei Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kissei Pharmaceutical Co E10 Chart

Kissei Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.27 1.22 1.18 1.24 1.20

Kissei Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.38 1.48 1.21 1.20 0.00

KSPHF vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kissei Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kissei Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kissei Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Kissei Pharmaceutical Co's Shiller PE Ratio falls into.


KSPHF
79GF Score
Kissei Pharmaceutical Co Ltd KSPHF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kissei Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kissei Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.421/112.7000*112.7000
=0.421

Current CPI (Mar. 2026) = 112.7000.

Kissei Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.550 98.100 0.632
201609 0.212 98.000 0.244
201612 0.556 98.400 0.637
201703 0.125 98.100 0.144
201706 0.392 98.500 0.449
201709 0.407 98.800 0.464
201712 0.691 99.400 0.783
201803 0.200 99.200 0.227
201806 0.533 99.200 0.606
201809 0.114 99.900 0.129
201812 0.178 99.700 0.201
201903 0.233 99.700 0.263
201906 0.399 99.800 0.451
201909 0.027 100.100 0.030
201912 0.273 100.500 0.306
202003 -0.144 100.300 -0.162
202006 0.343 99.900 0.387
202009 0.541 99.900 0.610
202012 0.421 99.300 0.478
202103 -0.230 99.900 -0.259
202106 0.718 99.500 0.813
202109 0.398 100.100 0.448
202112 0.220 100.100 0.248
202203 1.116 101.100 1.244
202206 0.265 101.800 0.293
202209 0.256 103.100 0.280
202212 0.537 104.100 0.581
202303 0.626 104.400 0.676
202306 0.502 105.200 0.538
202309 0.356 106.200 0.378
202312 0.411 106.800 0.434
202403 0.425 107.200 0.447
202406 0.588 108.200 0.612
202409 0.181 108.900 0.187
202412 0.537 110.700 0.547
202503 0.488 111.100 0.495
202506 0.747 111.700 0.754
202509 0.534 112.000 0.537
202512 0.500 113.000 0.499
202603 0.421 112.700 0.421

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $1.20 mean?
Kissei Pharmaceutical Co (KSPHF) has a E10 of $1.20 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Kissei Pharmaceutical Co and its competitors.
Is Kissei Pharmaceutical Co's E10 too high?
Kissei Pharmaceutical Co's current E10 is $1.20. Overall, Kissei Pharmaceutical Co has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Kissei Pharmaceutical Co's E10 compare to ZTS?
Kissei Pharmaceutical Co's E10 of $1.20 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Kissei Pharmaceutical Co and its competitors. Kissei Pharmaceutical Co's current E10 is $1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kissei Pharmaceutical Co stock overvalued right now?
Kissei Pharmaceutical Co (KSPHF) has a current E10 of $1.20. The stock's GF Value™ is $31.34, compared to a current price of $25.77 — trading 17.8% below its estimated fair value. The current E10 is $1.20. Kissei Pharmaceutical Co's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Kissei Pharmaceutical Co (KSPHF), the current E10 is $1.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kissei Pharmaceutical Co (KSPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Kissei Pharmaceutical Co stock appears to be undervalued. The current stock price of $25.77 is trading 17.8% below its estimated GF Value™ of $31.34.

Key valuation signals for KSPHF:

  • E10: $1.20
  • GF Value™: $31.34 vs. price of $25.77 (17.8% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the KSPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kissei Pharmaceutical Co Business Description

Other Exchanges 4547:Japan
Address 19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
79GF Score

Get the complete analysis for KSPHF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.77
Price
$31.34
GF Value